COSCIENS is a life science company with a diverse portfolio focused on the development of natural, plant-based active ingredients and engaged in the commercialization of pharmaceutical and diagnostic products. COSCIENS' natural active ingredient business leverages the Company's proprietary manufacturing and extraction technologies to develop avenanthramides and beta glucan active ingredients currently used in leading skincare brands worldwide. COSCIENS’ lead pharmaceutical product Macimorelin (Macrilen; Ghryvelin), is the first and only U.S. Food and Drug Administration (“FDA”) and European Medicines Agency (“EMA”) approved oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD).
Company Details
- Employees
- 6
- Address
- Toronto, Ontario, Ca
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://cosciensbio.com
- Keywords
- Biopharma, Active Ingredients, Pharma, Diagnostic tests, Natural Ingredients, Plant Based Ingredients, Oat Beta Glucan, AHGD, Avenanthramides, CHGD, All Natural, TSX.
- HQ
- Toronto, Ontario
Cosciens Biopharma Questions
Cosciens Biopharma's website is http://cosciensbio.com
Cosciens Biopharma's LinkedIn profile is https://www.linkedin.com/company/cosciens
Cosciens Biopharma has
6 employees.
View email and phone details for 6
employees at Cosciens Biopharma.
Cosciens Biopharma's industry is
Biotechnology Research
Cosciens Biopharma's top competitors are
Keen & Company,
Aeterna Zentaris Inc.,
Biocodex,
Camurus,
Ascendis Pharma,
Ceapro,
Ipsen,
Bioenvelop Inc.,
Elastrin Therapeutics,
Beone Medicines.
Cosciens Biopharma's categories are Biotechnology Research
